By Julie Grisham, MS, Science Writer/Editor | Monday, April 15, 2013
Genetic counselor Megan Harlan Fleischut discusses hereditary cancers and the services offered by Memorial Sloan-Kettering’s clinical genetics experts.
By Julie Grisham, MS, Science Writer/Editor | Friday, April 12, 2013
Memorial Sloan-Kettering’s Virtual Groups program offers patients private, online support and education sessions to participate in from home or work.
By Memorial Sloan-Kettering | Wednesday, April 10, 2013
Dr. Douer, leader of the research program in acute lymphoblastic leukemia, talks about how patients are treated by a caring team that includes physicians, nurses, social workers, and support staff.
By Julie Grisham, MS, Science Writer/Editor | Monday, April 8, 2013
Memorial Sloan-Kettering’s Physician-in-Chief, José Baselga, explains the findings from three studies on new targeted therapies for breast cancer.
In the Clinic
By Media Staff | Thursday, April 4, 2013
Early research led by investigators at Memorial Sloan-Kettering cautions against combining ipilimumab and vemurafenib for the treatment of metastatic melanoma.
In the Clinic
By Jim Stallard, MA, Writer/Editor | Wednesday, April 3, 2013
A new guideline has established standards for testing lung cancer tumors for genetic abnormalities, giving more patients a chance to benefit from targeted therapies.
By Media Staff | Tuesday, April 2, 2013
In his new role as Deputy Physician-in-Chief for Clinical Research, Paul Sabbatini aims to streamline, accelerate, and expand Memorial Sloan-Kettering’s clinical research program.
By Julie Grisham, MS, Science Writer/Editor | Thursday, March 28, 2013
A study identifies genetic variations that alter the risk of breast cancer in women who have a certain gene mutation.
By Memorial Sloan-Kettering | Wednesday, March 27, 2013
Dr. Sonoda, who performs minimally invasive procedures when possible, discusses how patients at Memorial Sloan-Kettering have the benefit of an entire team of physicians having input into their care.
By Memorial Sloan-Kettering | Friday, March 22, 2013
To treat his soft tissue sarcoma, 50-year-old Ron Kraemer chose Memorial Sloan-Kettering for care and support that could keep him playing music and working as a personal fitness trainer.
In the Clinic
By Jim Stallard, MA, Writer/Editor | Wednesday, March 20, 2013
Memorial Sloan-Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.
By Memorial Sloan-Kettering | Monday, March 18, 2013
Medical oncologist Dr. Chung specializes in working with patients who have leukemia and bone marrow failure syndromes, from diagnosis through treatment and general medical care.
By Esther Napolitano, BS, Science Writer/Editor | Thursday, March 14, 2013
Dr. Scardino discusses strategies for how physicians and patients can make the best use of PSA testing and prostate cancer treatment.
In the Lab
By Julie Grisham, MS, Science Writer/Editor | Wednesday, March 13, 2013
Scientists from Memorial Sloan-Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.
By Allyson Collins, MS, Science Writer/Editor | Tuesday, March 12, 2013
Gynecology Service Chief Richard Barakat comments on a recent study indicating that women treated by more-experienced physicians receive the most-appropriate care for this aggressive form of cancer.